Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/30/2025

Acute Sinusitis Management

Appropriate Antibiotic Selection

  • The American Academy of Pediatrics recommends amoxicillin (with or without clavulanate) as the first-line antibiotic treatment for acute bacterial sinusitis 3, 4
  • The American Family Physician suggests that narrow-spectrum agents targeting the most common pathogens (Streptococcus pneumoniae and Haemophilus influenzae) are recommended as first-line therapy for patients with severe or persistent moderate symptoms of bacterial sinusitis requiring antibiotics 1, 2
  • The standard course of therapy is typically 10-14 days for acute bacterial sinusitis, as recommended by the Journal of Allergy and Clinical Immunology 5, 6

Diagnostic Considerations and Treatment Approach

  • Acute bacterial sinusitis typically presents as a persistent upper respiratory infection (10-14 days without improvement) or worsening symptoms after 5-7 days, according to the Journal of Allergy and Clinical Immunology 5, 7
  • The American Family Physician guidelines emphasize that most cases of acute sinusitis are viral and self-limiting, not requiring antibiotic therapy 1, 2
  • For mild-moderate symptoms lasting less than 7 days, symptomatic treatment only (decongestants, analgesics) is recommended by the American Family Physician 1, 2

Common Pitfalls to Avoid

  • Using broad-spectrum antibiotics like piperacillin-tazobactam for community-acquired infections leads to unnecessary antimicrobial resistance, as stated by the Journal of Allergy and Clinical Immunology and Clinical Microbiology and Infection 5, 7
  • Treating viral sinusitis with antibiotics is not recommended, as most cases resolve without antibiotics within 7-10 days, according to the American Family Physician 1, 2
  • Failure to consider antibiotic resistance patterns when selecting therapy can lead to ineffective treatment, with up to 50% of S. pneumoniae being relatively or highly resistant to penicillin, as reported by the Journal of Allergy and Clinical Immunology 6